我国中成药临床综合评价研究热点与趋势分析

Analysis of research hotspots and trend of the clinical comprehensive evaluation of Chinese patent medicine in China

目的分析我国中成药临床综合评价研究领域的研究现状、热点与趋势。方法基于中国知网、维普网和万方数据,以中成药临床综合评价为主题进行检索,检索时限为建库至2022年10月30日。采用CiteSpace 6.1.R3和VOSviewer软件对我国中成药临床综合评价相关文献的年度发文情况、作者、机构、关键词等信息进行可视化分析。结果与结论本研究共纳入中成药临床综合评价相关文献1460篇,年发文量总体呈增长趋势。纳入文献共有发文作者714位,发文量较多的机构有中国中医科学院、北京中医药大学和天津中医药大学等,发文作者团队及机构间合作较少;高频关键词为中成药、安全性、不良反应、合理用药等;研究热点为中成药的安全性评价和有效性评价;加强中成药处方点评,构建多维度、多准则的中成药合理用药临床综合评价体系,保障中成药合理应用可能成为该领域的研究趋势。

OBJECTIVE To analyze the research status,hotspots,and trend of the clinical comprehensive evaluation of Chinese patent medicine in China.METHODS Based on CNKI,VIP and Wanfang database,clinical comprehensive evaluation of Chinese patent medicine was used as the subject of retrieval,and the retrieval time was from the inception to October 30th,2022.CiteSpace 6.1.R3 and VOSviewer were used to conduct a visualization analysis of the relative literature of clinical comprehensive evaluation of Chinese patent medicine in terms of annual publication quantity,authors,institutions,keywords,etc.RESULTS&CONCLUSIONS A total of 1460 pieces of literature related to the clinical comprehensive evaluation of Chinese patent medicine were included.The overall annual publication quantity showed a growth trend.There were 714 authors in the included literature.The institutions with a large publication quantity included the Chinese Academy of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Tianjin University of Traditional Chinese Medicine,etc.,and there was little cooperation among the authors and institutions.High-frequency keywords included Chinese patent medicine,safety,adverse drug reactions,rational drug use,etc.Research hotspots focused on the safety and effectiveness evaluation of Chinese patent medicine.It may be a research trend in this field to strengthen the prescription review of Chinese patent medicine,and build a multi-dimensional and multi-criteria clinical comprehensive evaluation system for the rational use of Chinese patent medicine.